Aleniglipron
Aleniglipron (GSBR-1290) is an oral, small-molecule GLP-1 receptor agonist that engages deep orthosteric binding sites. It has demonstrated efficacy in preclinical research for reducing body weight and enhancing insulin sensitivity, supporting its investigation in metabolic disease models including obesity and type 2 diabetes.
Product Specifications
CAS Number
2685823-26-9
Product Name Alternative
GSBR1290, GSBR-1290
Field of Research
Pharmacology & Drug Discovery
Purity
99.79% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:3.3 mg/mL (3.6 mM) ; DMSO:80 mg/mL (87.34 mM)
Smiles
C[C@@H]1[C@] (C1) (N2C=3C (C=C2C (=O) N4[C@@H] (C) C5=C (N (N=C5CC4) C6=CC (C) =C (F) C (C) =C6) N7C (=O) N (C=C7) C8=CC (NC) =C (P (CC) (CC) =O) C=C8) =CC (=CC3) C9CCOCC9) C%10=NOC (=O) N%10
Molecular Formula
C49H55FN9O6P
Molecular Weight
915.99
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
